Study of effect of an Ayurvedic Remedy (Vyanga Nashak Arka) in Managing Facial Dark Patches (Melasma)

A Clinical Study on the Efficacy of Vyanga Nashak Arka in the Management of Vyanga with the special reference to Melasma. - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/02/103518

Enrollment

Registered

2026-02-10

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L811- Chloasma

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Clinically diagnosed cases of Vyanga (Melasma) as per Ayurvedic features Niruja (painless), Shyava (bluish black), Tanu Mandalas (macules) on the face) and modern clinical features. 2.Patients fulfilling the diagnostic criteria, between the age group 16 and 60 years, irrespective of sex, religion, occupation, and chronicity were selected for the study. 3.Willingness to participate voluntarily and provide written informed consent. 4.Ability to comply with the study protocol and follow-up schedule.

Exclusion criteria

Exclusion criteria: 1.Melasma associated with systemic or endocrine disorders (e.g., thyroid dysfunction, PCOD, hepatic dysfunction). 2.Pregnant or lactating women, due to hormonal variability and safety concerns. 3.Concurrent dermatological conditions affecting the face (e.g., acne vulgaris, eczema, rosacea). 4.Known allergy to any of the ingredients used in Vyanga Nashak Arka. 5.Participation in any other clinical trial within the past 3 months.

Design outcomes

Primary

Measure	Time frame
The primary outcomes will be measured based on clinical outcomes, MASI score providing the efficacy of the test drug for the treatment of vyanga(melasma)Timepoint: Literature review, collection of samples, pharmacognosy and chemical analysis-3 months Preparation of test drug, Experimental study-3 months Clinical study-10 months Statistical analysis and compilation of research work-2 months Total-18 months	—

Measure

Time frame

The primary outcomes will be measured based on clinical outcomes, MASI score providing the efficacy of the test drug for the treatment of vyanga(melasma)Timepoint: Literature review, collection of samples, pharmacognosy and chemical analysis-3 months Preparation of test drug, Experimental study-3 months Clinical study-10 months Statistical analysis and compilation of research work-2 months Total-18 months

—

Secondary

Measure	Time frame
The Effect of the test drug medication alters the quality of the life that will be evaluated after completion of the treatment..Timepoint: Literature review, collection of samples, pharmacognosy and chemical analysis-3 months Preparation of test drug, Experimental study-3 months Clinical study-10 months Statistical analysis and compilation of research work-2 months Total-18 months	—

Countries

India

Contacts

Public ContactAjmal Hossain

Institute of Post Graduate Ayurvedic Education and Research at SVSP Hospital

dr.sureshkjaiswara@gmail.com9681098261

Outcome results